BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6707169)

  • 1. Determination of 3,7-dimethyl-1-(5-oxohexyl)-xanthine (pentoxifylline) and its 3,7-dimethyl-1-(5-hydroxyhexyl)-xanthine metabolite in the plasma of patients with multiple diseases using high-performance liquid chromatography.
    Rieck W; Platt D
    J Chromatogr; 1984 Feb; 305(2):419-27. PubMed ID: 6707169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of pentoxifylline and a major metabolite, 3,7-dimethyl-1-(5'-hydroxyhexyl)xanthine, by high-performance liquid chromatography.
    Luke DR; Rocci ML
    J Chromatogr; 1986 Jan; 374(1):191-5. PubMed ID: 3949928
    [No Abstract]   [Full Text] [Related]  

  • 3. High-performance liquid chromatographic analysis of pentoxifylline and 1-(5'-hydroxyhexyl)-3,7-dimethylxanthine in whole blood.
    Grasela DM; Rocci ML
    J Chromatogr; 1987 Aug; 419():368-74. PubMed ID: 3667793
    [No Abstract]   [Full Text] [Related]  

  • 4. High-performance liquid chromatographic determination of pentoxifylline and its hydroxy metabolite in human plasma.
    Garnier-Moiroux A; Poirier JM; Cheymol G; Jaillon P
    J Chromatogr; 1987 Apr; 416(1):183-8. PubMed ID: 3597635
    [No Abstract]   [Full Text] [Related]  

  • 5. Determination of pentoxifylline and its 5-hydroxy metabolite in human plasma by solid-phase extraction and high-performance liquid chromatography with ultraviolet detection.
    Musch G; Hamoir T; Massart DL
    J Chromatogr; 1989 Oct; 495():215-26. PubMed ID: 2613806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of oxpentifylline and a metabolite, 1-(5'-hydroxyhexyl)-3,7-dimethylxanthine, by gas--liquid chromatography using a nitrogen-selective detector.
    Bryce TA; Burrows JL
    J Chromatogr; 1980 Mar; 181(3-4):355-61. PubMed ID: 7391152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous determination of pentoxifylline and its hydroxy metabolite in plasma by high-performance liquid chromatography.
    Chivers DA; Birkett DJ; Miners JO
    J Chromatogr; 1981 Sep; 225(1):261-5. PubMed ID: 7298755
    [No Abstract]   [Full Text] [Related]  

  • 8. [Determination of pentoxifylline and its major metabolites in human plasma using HPLC].
    Ostrovská V; Pechová A; Kovácová D; Svobodová X; Kusala S
    Cesk Farm; 1990 Jun; 39(4):158-60. PubMed ID: 2393914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary excretion of pentoxifylline and its metabolites by standardbred mares.
    Kwong EC; Chen FC; Young LM
    Can J Vet Res; 1989 Apr; 53(2):147-53. PubMed ID: 2713780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of pentoxifylline clearance by cimetidine.
    Luke DR; Rocci ML; Hoholick C
    J Pharm Sci; 1986 Feb; 75(2):155-7. PubMed ID: 3958924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of 1-(3'-carboxypropyl)-3,7-dimethylxanthine and 1-(4'-carboxybutyl)-3,7-dimethylxanthine, two major metabolites of oxpentifylline, in urine by high-performance liquid chromatography.
    Bryce TA; Burrows JL; Jolley KW
    J Chromatogr; 1985 Nov; 344():397-402. PubMed ID: 4086565
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of liquid chromatography-tandem mass spectrometry for the analysis of pentoxifylline and lisofylline in plasma.
    Kyle PB; Adcock KG; Kramer RE; Baker RC
    Biomed Chromatogr; 2005 Apr; 19(3):231-6. PubMed ID: 15627284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous determination of pentoxifylline and three metabolites in biological fluids by liquid chromatography.
    Lambert WE; Yousouf MA; Van Liedekerke BM; De Roose JE; De Leenheer AP
    Clin Chem; 1989 Feb; 35(2):298-301. PubMed ID: 2914378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous estimation of lisofylline and pentoxifylline in rat plasma by high performance liquid chromatography-photodiode array detector and its application to pharmacokinetics in rat.
    Italiya KS; Sharma S; Kothari I; Chitkara D; Mittal A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Sep; 1061-1062():49-56. PubMed ID: 28704725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interference potential of pentoxifylline and its major metabolite with theophylline assays.
    Cummings DM; Rocci ML; Green P; Saccar C
    Am J Hosp Pharm; 1985 Dec; 42(12):2717-8. PubMed ID: 3909811
    [No Abstract]   [Full Text] [Related]  

  • 16. Determination of pentoxifylline and its major metabolites in microbial extracts by thin-layer and high-performance liquid chromatography.
    Smith RV; Yang SK; Davis PJ; Bauza MT
    J Chromatogr; 1983 Dec; 281():281-7. PubMed ID: 6668334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection and determination of 3,7-dimethyl-6-(5-oxo-hexoxy)-2H-purine-2-one, a byproduct of pentoxifylline synthesis].
    Proksa B; Michalák K; Nevydal J
    Pharmazie; 1984 Jun; 39(6):429-30. PubMed ID: 6483952
    [No Abstract]   [Full Text] [Related]  

  • 18. Study of the solid phase extraction of pentoxifylline and its major metabolite as a basis of their rapid low concentration gas chromatographic determination in serum.
    Marko V; Bauerová K
    Biomed Chromatogr; 1991 Nov; 5(6):256-61. PubMed ID: 1760592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simple high-performance liquid chromatographic method for determination of pentoxifylline in human plasma.
    Jia Woei Wong ; Kah Hay Yuen ; Kok Khiang Peh
    J Chromatogr B Biomed Sci Appl; 1998 Sep; 716(1-2):387-91. PubMed ID: 9824257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of pentoxifylline and its metabolites in human plasma by high-performance liquid chromatography with solid-phase extraction.
    Mancinelli A; Pace S; Marzo A; Martelli EA; Passetti G
    J Chromatogr; 1992 Mar; 575(1):101-7. PubMed ID: 1517286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.